Dual antiplatelet therapy after coronary artery bypass grafting: A safe option after all? Comment on a published meta-analysis

Autores da FMUP

• Francisca Almeida Saraiva

  Autor

• Joaquim Adelino Correia Ferreira Leite Moreira

  Autor

Participantes de fora da FMUP

• Rocha Gomes, JN

Unidades de investigação

• Cirurgia e Fisiologia

• RISE-Health

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• Coronary Artery Bypass; Dual Anti-Platelet Therapy; Platelet Aggregation Inhibitors; Ticlopidine; acetylsalicylic acid; clopidogrel; antithrombocytic agent; ticlopidine; bleeding; coronary artery bypass graft; drug dosage form comparison; drug safety; dual antiplatelet therapy; Europe; follow up; human; incidence; Letter; meta analysis (topic); monotherapy; peer review; practice guideline; prescription; risk factor; survival factor; United States; coronary artery bypass graft